(a) By January 1, 2022, the California Research Bureau shall report to the Legislature on the implementation of this chapter, including, but not limited to, this chapter’s effectiveness in addressing the following goals:
(1) Promoting transparency in pharmaceutical pricing for the state and other payers.
(2) Enhancing understanding about pharmaceutical spending trends.
(3) Assisting the state and other payers in management of pharmaceutical drug costs.
(b) A report submitted pursuant to subdivision (a) shall be submitted in compliance with Section 9795 of the Government Code.
(c) Notwithstanding any other law, implementation of this chapter shall be subject to review by the appropriate policy committees of the Legislature. The review shall be performed as if this chapter were scheduled to be repealed on January 1, 2023.
(d) This section shall remain in effect only until January 1, 2024, and as of that date is repealed.
(Added by Stats. 2017, Ch. 603, Sec. 4. (SB 17) Effective January 1, 2018. Repealed January 1, 2024, by its own provisions.)
Last modified: October 25, 2018